Browsing by Author Bridges, Ian

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)Citation
2017Long-term safety, tolerability, and efficacy of evolocumab in patients with heterozygous familial hypercholesterolemiaSullivan, David; Bridges, Ian; Coll, Blai; Dent, Ricardo; Descamps, Oliver; Hovingh, G Kees; Lira, Armando; Masana, Luis; Raal, Frederick J; Stefanutti, Claudia; NH&MRC Clinical Trials CentreLong-term safety, tolerability, and efficacy of evolocumab in patients with heterozygous familial hypercholesterolemia, Journal of Clinical Lipidology, vol.11, 6, 2017,pp 1448-1457
2015PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trialSullivan, David; Bridges, Ian; Burgess, Leslie; Cariou, B; Civeira, Fernando; Dufour, Robert; Gaudet, Daniel; Gouni-Berthold, Ioanna; Hovingh, G Kees; Langslet, Gisle; Olsson, Anders; Raal, Frederick J; Scott, Rob; Scott, Russell; Somaratne, Ransi; Stein, Evan; Turner, Traci; Wasserman, Scott M.; NH&MRC Clinical Trials CentrePCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial, The Lancet, vol.385, 9965, 2015,pp 331-340